1-3 of 3
Renee S. McCormick
Close
Sort by
Journal Articles

Preclinical Analysis of the Combined Activity of SGN-40, Anti-CD40 Monoclonal Antibody, with Rituximab in Non-Hodgkin Lymphoma.

Timothy S. Lewis, Renee S. McCormick, Julie A. McEarchern, Kim Kissler, Ivan J. Stone, Hans-Peter Gerber, Jonathan G. Drachman, Iqbal Grewal, Che-Leung Law
Journal: Blood
Blood (2008) 112 (11): 1583.
https://doi.org/10.1182/blood.V112.11.1583.1583
Published: 2008
Journal Articles

The Humanized Anti-CD40 Monoclonal Antibody, SGN-40, Potentiates Chemotherapy Regimens in NHL Xenograft Models Via Pro-Apoptotic Signaling.

Timothy S. Lewis, PhD, Renee S. McCormick, B.S., Kim Kissler, B.S., Ivan J. Stone, B.S., Mechthild Jonas, Ph.D., May S.K. Sutherland, Ph.D., Hans-Peter Gerber, Ph.D., Jonathan G. Drachman, M.D., Iqbal S. Grewal, Ph.D., Che-Leung Law, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2342.
https://doi.org/10.1182/blood.V110.11.2342.2342
Published: 2007
Journal Articles

The Anti-CD30 Monoclonal Antibody SGN-30 Inhibits Hodgkins Disease Growth and Sensitizes Cells to Established Chemotherapeutics.

Charles G. Cerveny, MS, Che-Leung Law, PhD, Renee S. McCormick, BS, Joel S. Lenox, MS, Kevin J. Hamblett, PhD, Lori E. Westendorf, BS, Andrew K. Yamane, BS, Joseph M. Petroziello, MS, Joseph A. Francisco, PhD, Alan F. Wahl, PhD
Journal: Blood
Blood (2004) 104 (11): 2639.
https://doi.org/10.1182/blood.V104.11.2639.2639
Published: 2004